The downregulation of GFAP and AQP4 in astrocytes may indicate dysfunction, and our findings suggest that ZLE and tricin have the potential to counteract AD progression by preserving astrocyte function, particularly within the Aβ clearance system. This evidence concerns the gene GFAP and Alzheimer disease.